Its been effective (first month 236 to 216) with gym and dietician inputs
The extended half-life enables once-weekly subcutaneous dosing, which is the standard clinical approach [1]
Potential Side effects The most common side effects of Tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder)
Microdose GLP-1 may be an option for adults interested in supporting overall wellness, healthy aging, or metabolic health with a gentler approach than standard GLP-1 doses